Integra LifeSciences Holdings

Healthcare · Medical Devices

16.10$ +1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Integra LifeSciences Holdings (IART) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,635 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IART
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	13	15	18	43	65	93	113	186	230	278	419	550	655	682	732	780	831	836	928	883	992	1,188	1,472	1,518	1,372	1,542	1,558	1,542	1,611	1,635
Cost of Revenue	4.7	5.2	6.1	22	27	36	46	71	87	106	168	215	253	245	268	299	314	334	353	327	349	436	571	565	521	598	587	657	728	790
Gross Profit	8.4	9.5	11	21	38	57	67	115	143	172	251	336	402	438	464	481	516	502	576	556	643	753	901	953	851	945	970	885	882	845
Research & Development	6.3	6.4	8.4	8.7	7.5	8.0	8.3	13	14	12	26	31	60	44	48	51	51	52	52	51	58	63	78	80	77	93	101	104	115	99
Selling, General & Administrative	9.6	20	16	22	44	32	41	59	99	98	158	225	281	281	305	358	373	394	446	416	456	624	691	688	595	637	616	657	717	700
Total Operating Expenses	18	29	26	33	57	43	45	75	118	116	192	268	354	340	365	426	443	459	510	477	528	708	790	859	700	747	731	773	854	777
Operating Income	-9.5	-19	-14	-12	-18	14	19	40	25	56	59	67	47	98	99	55	74	-3.6	66	80	115	45	111	94	151	197	239	112	28	68
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11	14	30	23	18	28	22	20	22	24	26	35	65	54	72	50	50	51	71	86
Pre-Tax Income	-7.6	-17	-12	-7.8	-11	16	23	43	28	55	48	60	31	73	82	28	52	-25	43	61	90	11	57	60	94	215	214	81	-18	-564
Income Tax Expense	-2.0	-2.0	-1.8	-1.8	0.1	-11	-13	16	11	18	19	27	-3.9	22	16	0.5	11	-7.8	9.0	54	16	-53	-3.4	9.9	-40	46	33	13	-11	-47
Net Income	-7.5	-17	-12	-6.0	-11	26	35	27	17	37	29	33	35	51	66	28	41	-17	34	-3.5	75	65	61	50	134	169	181	68	-6.9	-516
EBITDA	-7.5	-17	-17	-12	-13	21	26	49	36	69	59	67	79	136	140	106	116	40	172	196	232	135	241	224	268	366	385	256	193	-326

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings